United Therapeutics CEO Martine A. Rothblatt reports sale of $5.7 million in common shares
UTHR•United Therapeutics CEO Martine A. Rothblatt sold 9,500 common shares on Oct. 30, 2026, in a sale valued at $5.7 million.
1. Share transactions
Rothblatt also exercised 9,500 stock options at $117.76 per share on Oct. 30, leaving 119,410 stock options held indirectly through a trust. After the transactions, she held 324,443 common shares through transacting trusts and another 40,513 shares directly.
